Showing results (1-10 of 3) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|February 21, 2013
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISAB J Werth, C Vidaillac, K P Murray, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 8, 2017
Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimenB J Werth, R Jain, A Hahn, et al.Antimicrobial Agents and Chemotherapy|June 25, 2014
Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalisB J Werth, M E Steed, C E Ireland, et al.Pageof 1